The issues of poor recruitment to clinical trials and the best investigator sites are not contemporary ones. There is growing interest in understanding barriers to enrolling all eligible patients at clinical sites into clinical trials especially since public opinion generally supports participation in research. While systematic investigations are underway, Clin Ops professionals must keep studies moving forward, utilizing the best practices available to develop sustainable project management strategies. In some cases, barriers exist to getting the best available data for robust decision-making; in other cases, the data are freely available, but the tools needed to make use of the data are not easily accessible or affordable.
The value of the integration is to extend the annotation of an investigator record with the attributes of the trials they participated in. This allows search by disease, drug, target, biomarker, sponsor, and study protocol.
We recently undertook a project to reconcile investigators records from ClinicalTrials.gov, FDA/BMIS and CMS/Sunshine. The problem we wished to solve is:
Can we build a coherent transcript of a clinical trial investigators activity by integrating data across these sources?
Keeping up with clinical trials information is critical for clinical operations professionals (aka
ClinOps). However, a productivity gap exists between unwieldy and disparate public trial search engines and clinical trial management solutions.
In this post, we describe our latest thinking on how to Position TrialIO and offer links to our latest White Paper and Video suite.
Search results are iterative allowing new filters to be applied to the last result. Together with the ability to search only specific sections, ie., Inclusion Criteria, TrialIO approximates a workflow engine, without the need for computer programming.
Last week we undertook a major sub-project to "clean" the investigator and site profiles. I will detail the statistics in a separate blog post, but here are some high level details that might interest you:
Last week was an amazing week for TrialIO's journey to market!
As mentioned in the article, the FDA requires that pharma companies report clinical trial activities at ClinicalTrials.gov. Thus, actively mining this resource is a key component of any competitive intelligence or trial planning exercise.
Since I am connecting with clinical trial users each with unique and valuable input for the product and the community, I want to use this forum to share that knowledge and update you on the software changes and solicit feedback on features and use cases.